• Home
  • NEW DAY MEDICINE
  • 3 (65) 2024
  • 30 -3 (65) 2024 - Navruzova R.S., Kurbanov B.B., Kurbanov D.D. - ANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PREGNANT WOMEN WITH HYPERTENSION CONDITIONS

30 -3 (65) 2024 - Navruzova R.S., Kurbanov B.B., Kurbanov D.D. - ANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PREGNANT WOMEN WITH HYPERTENSION CONDITIONS

ANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PREGNANT WOMEN WITH HYPERTENSION CONDITIONS

Navruzova R.S. Tashkent Pediatric Medical Institute

Kurbanov B.B. Tashkent Pediatric Medical Institute

Kurbanov D.D. Tashkent Pediatric Medical Institute

Resume

The reasons for the development of hypertensive conditions during pregnancy are multifactorial, complex and not fully understood. The purpose of this study was to study the main clinical and laboratory changes in pregnant women with hypertensive conditions of varying severity. Characteristic clinical and laboratory changes are given depending on the severity.

Keywords: Preeclampsia, hypertension, pregnancy

First page

144

Last page

148

For citation: Navruzova R.S., Kurbanov B.B., Kurbanov D.D. - ANALYSIS OF CLINICAL AND LABORATORY STUDIES OF PREGNANT WOMEN WITH HYPERTENSION CONDITIONS//New Day in Medicine 3(65)2024 144-148 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Аюпова Ф. М., Хамраев Х. Х., Махмудова С. Э. Молекулярно-генетические факторы преэклампсии и их взаимосвязь с течением и исходами беременности // Журнал Репродуктивного Здоровья и Уро-Нефрологических Исследований. 2020;1:2.
  2. Ихтиярова Г. А., Негматуллаева М. Н., Туксанова Д. И. Современные аспекты коррекции гемодинамических нарушений у родильниц с преэклампсией легкой степени // Педиатрия (узб). 2003; Спец.вып:97-99.
  3. Захидова Н. Э., Хегай Т. Р., Арипова Т. У. Мета-анализ факторов риска развития преэклампсии // Журнал теоретической и клинической медицины. 2018;2:72-76.
  4. Абдурахманова Д. Н., Мадаминова М. Ш., Садуллаева А. Ф. Преэклампсия-актуальная проблема в современном акушерстве // International scientific review. 2016;5(15).
  5. Мирзаева Д. Б. Особенности течения родов у женщин с тяжелой преэклампсией // Вестник Российского государственного медицинского университета. 2015;2:50-51.
  6. Курбанов Б. Б. Морфофункциональные изменения плаценты и их взаимосвязь с уровнем белка Sflt1 в крови беременных с преэклампсиями различной степени // Вестник экстренной медицины. 2020;13(1-2):87-91.
  7. Sun Y. et al. Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the study of optimal treatment in hypertensive patients with anti-AT1-receptor autoantibodies trial // Journal of the American Society of Hypertension. 2014;8(1):21-27.
  8. Begum R., Begum A., Johanson R. A low dose (“Dhaka”) magnesium sulphate regime for eclampsia // Acta Obstet. Gynecol. Scand. 2001;80(11):998-1002.
  9. Tejera E. et al. Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesis // BMC medical genomics. 2017;10(1): 1-19.
  10. Wang L. et al. Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia // American journal of obstetrics and gynecology. 2006;195(1):162-171.
  11. Soltani-Zangbar M. S. et al. Angiotensin type 2 receptor gene polymorphisms and susceptibility to preeclampsia // Journal of reproduction infertility. 2018;19(2):95.
  12. Srinivas S., Morrison A., Elovitz M. 760: Genetic contribution of the renin-angiotesin system to preeclampsia // American Journal of Obstetrics Gynecology. 2009;201(6):S273.
  13. Semianiv M. M. et al. Association of AGTR1 (rs5186), VDR (rs2228570) genes polymorphism with blood pressure elevation in patients with essential arterial hypertension // Journal of Medicine and Life. 2021;14(6):782.
  14. Zhao L. Genetics of Preeclampsia: Identifying Risk Variants Using Epidemiological, Computational, and Experimental Methods. – Yale University, 2012.
  15. Belfort M., Varner M. Cerebral perfosion, perfusion pressure and not cerebral blood flow may be the critical determinant of intracranial injury in preeclampcia: a new hypoteses // Am J Obstet Gynec. 2002;107:625-634.
  16. Biasiutti F., Strebel J. Anticoagulation and antiaggregation during pregnancy // Ther Umsch. 2003;60(1):54-58.
  17. Blood cell lead, calcium, and magnesium levels associated with pregnancy-induced hypertension and preeclampsia / E. B. Davson, D. R. Evans, R. Kelly // Biol. Trace Elem. Res. 2000;74(2):107-116.
  18. Rahimi Z. et al. Endothelial nitric oxide synthase (eNOS) 4a/b and G894T polymorphisms and susceptibility to preeclampsia // Journal of Reproduction & Infertility. 2013;14(4):184.
  19. Kim Y. J. et al. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations // Twin Research and Human Genetics. 2008;11(1):77-83.
  20. Zhao L., DeWan A. T., Bracken M. B. Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis // The Journal of Maternal-Fetal & Neonatal Medicine. 2012;25(12):2676-2680.

    file

    download